| Literature DB >> 26041752 |
Eline H Schreuders1, Arlinda Ruco2, Linda Rabeneck3, Robert E Schoen4, Joseph J Y Sung5, Graeme P Young6, Ernst J Kuipers1.
Abstract
Colorectal cancer (CRC) ranks third among the most commonly diagnosed cancers worldwide, with wide geographical variation in incidence and mortality across the world. Despite proof that screening can decrease CRC incidence and mortality, CRC screening is only offered to a small proportion of the target population worldwide. Throughout the world there are widespread differences in CRC screening implementation status and strategy. Differences can be attributed to geographical variation in CRC incidence, economic resources, healthcare structure and infrastructure to support screening such as the ability to identify the target population at risk and cancer registry availability. This review highlights issues to consider when implementing a CRC screening programme and gives a worldwide overview of CRC burden and the current status of screening programmes, with focus on international differences. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.Entities:
Keywords: COLONOSCOPY; COLORECTAL ADENOMAS; COLORECTAL CANCER; COLORECTAL CANCER SCREENING; COLORECTAL NEOPLASM
Mesh:
Year: 2015 PMID: 26041752 DOI: 10.1136/gutjnl-2014-309086
Source DB: PubMed Journal: Gut ISSN: 0017-5749 Impact factor: 23.059